Pressure Enabled Intrapancreatic Delivery of SD-101 With Checkpoint Blockade for Locally Advanced Pancreatic Adenocarcinoma

NCT05607953 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced Pancreatic Adenocarcinoma

Interventions

DRUG: SD-101
BIOLOGICAL: anti-PD-1

Sponsor

TriSalus Life Sciences, Inc.